Sangamo BioSciences to Present at Two Upcoming Investor C... ( RICHMOND Calif. Sept. 29 /- Sanga...)

Sangamo BioSciences to Present at Two Upcoming Investor Conferences

Date:9/29/2008

RICHMOND, Calif., Sept. 29 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic development programs and an overview of the company's business strategy at 11:30 a.m. (ET) on Monday, October 6, 2008, at the 2008 JMP Securities Healthcare Focus Conference and at 8:40 a.m. (ET) on Tuesday, October 7, 2008 at the William Blair Small Cap Conference. Both conferences are being held in New York City.

The presentations will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentations will be archived on the Sangamo website for two weeks after the events.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy and ALS. Other therapeutic development programs are focused on cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo i
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/5/2009)..., SAN DIEGO, CA, November 5, 2009 /PRNewswire-Firs...y focused on using proprietary taste receptor-base...s for the food, beverage, and ingredient supply in...ported financial results for the third quarter end... for the third quarter of 2009, compared to $4.0 m...

(Date:11/5/2009)... Drug safety specialty firm B...arning and Informatics earned the Certified Profes...redential from the American Society for Training a...chelle Flewell has more than fifteen years of medi...ence and is responsible for the development of the...

(Date:11/4/2009)... The Human Anthrax Vaccine Pr...as completed the feature film "A Call to Arms...cumentary "Fatal Immunity: The Human Anthrax ... clear and present danger of top secret government...ines with no accountability to its victims. It is...

(Date:11/4/2009)..., EMERYVILLE, Calif., Nov. 4 /PRNewswire-FirstCall...oday announced that it will present at the Credit ...day, November 11, at 9:30 a.m. Mountain Time (8:30...s a live webcast of the presentation on our websit...t-Calendar ,, It is recommended that listener...

[0] SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS [0] BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification [0] Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing [0] Onyx Pharmaceuticals to Present at the Credit Suisse 18th Annual Healthcare Conference

...Performance, Expanding Franchises, Creative Go to ... Investors , , INDIANAPOLIS, Feb. 10 Dow AgroS...tions was the focus of a recent presentation to in... of Dow AgroSciences. Dow AgroSciences is a wholl...SE: DOW ). Peribere spoke to investors today at...

..., N.J., Feb. 10 Johnson & Johnson Pharmaceuti...) announced today that the Food and Drug Administr...egarding the company,s supplemental New Drug Appli...one) Long-Acting Injection. The sNDA, submitted in...TA(R) for adjunctive maintenance treatment to dela...

...E, Feb. 10 A $50,000 investment fund will be awar... Society and Washington,Biotechnology and Biomedic...Investment Forum, to be held February 24, 2009, 2:... Accredited investors, entrepreneurs, and busine...ife Sciences Investment Forum. There will be seve...

Other Biology Technology:Dow AgroSciences Delivering Beyond Expectations 2 Dow AgroSciences Delivering Beyond Expectations 3 FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder 2 FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder 3 FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder 4 FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder 5 ZINO Society Spurring Investments, 12 Life Sciences Companies to Vie for $50,000 ZINO Life Fund 2

Dow AgroSciences Delivering Beyond Expectations FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder ZINO Society Spurring Investments, 12 Life Sciences Companies to Vie for $50,000 ZINO Life Fund

(Date:11/4/2009)... -- What,s the cost of saving a teenage life? When... from prescription medication abuse, there,s no pr...y be unaware that the lock-boxes they,ve installed...imebomb of prescription drugs. That,s why MEDNET(T...upplies, has formed an exclusive partnership with ...

(Date:11/4/2009)... Global Rainmakers, Inc., an intellectual property...today announced that the company has exited its "s...lize its suite of technologies designed to leverag... During the past four years, the company has spent... a series of core--but expandable--technologies bu...

(Date:11/4/2009)...lencoe Software, Inc., the commercial arm of the O...p://openmicroscopy.org ), is proud to announce it...Biology,s exciting new project titled "The Cell: A...M stimulus grant through the National Institutes o...art of the American Reinvestment and Recovery Act,...

Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2 MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3 Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2 Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3 Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2 Medical food reduces medical costs and use of anti convulsant medication 10533 1 Medical food reduces medical costs and use of anti convulsant medication 10533 2 Morehead Presents Webinar on 26apos 3BA Two Pronged Strategy to Reduce Nurse Turnover 26apos 3B 60125 1 Morehead Presents Webinar on 26apos 3BA Two Pronged Strategy to Reduce Nurse Turnover 26apos 3B 60125 2 Patients who Participated in Pleio GoodStart 28TM 29 Refilled 30 25 Sooner and 40 25 More Averaging 2 Additional Rx Refills per Patient 5720 1 Patients who Participated in Pleio GoodStart 28TM 29 Refilled 30 25 Sooner and 40 25 More Averaging 2 Additional Rx Refills per Patient 5720 2

[0] MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse [0] Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality [0] Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell

..., Byproducts from the electronics, fuel, chemica...oxic heavy metals like cadmium and lead can seep i...in the soil, these dangerous materials can render ... environmental, health and financial reasons, new ...icals from America,s soil. , Now, an innovative T...

..., Mutations that help HIV hide from the immune sy...how an international team of researchers in the Ap...ine . The study was published online on March 23. ...mune proteins called HLA (short for human leukocyt... of the virus on the surface of the cell. The T ce...

..., Here is the latest American Chemical Society (A...irs. It has news from ACS, 34 peer-reviewed journa...the individual journal or the American Chemical So...Pac Archive: http://portal.acs.org/portal/PublicW...TICLE # 1 FOR IMMEDIATE RELEASE, Solving the myste...

A dirty job but ...HIV pays a price for invisibility American Chemical Society Weekly PressPac -- April 8, 2009

...rogressive centrifuge design and manufacturing, Th... and Centra-CL3R (refrigerated) general purpose mo...y., Quality Control Over Sample Preparation ...otocols and has speed and accuracies to the neares...

...fluorescent and highly photostable FluoSpheres mic...iety of applications requiring probes that can del...other macromolecule-labeled microspheres have hydr...-target surfaces in some applications. This nonspe...

...se centrifuge offers both high-speed and high-vol...rotor options, making it ideal for a wide variety ...lity , High-speed (up to 15,000 rpm and 21,000 ...ng bucket rotors , Accommodates tube volumes fro...

...sed, high throughput, water bath thermal cycler ca...icroplates. This equates to 9,216 reactions per ru...idly transfers a basket of plates between three wa...hat are considerably faster than those of peltier ...

Biology Products:

Thermo Scientific IEC Centra-CL3 from Thermo Scientific BlockAid blocking solution *for use with microspheres* from Molecular Probes (Invitrogen)Thermo Scientific IEC Centra-CL5R from Thermo Scientific H2OBIT Thermal Cycler with Peel Seal Basket for 24 x 384-well plates from ABgene

Sangamo BioSciences to Present at Two Upcoming Investor C...( RICHMOND Calif. Sept. 29 /- Sanga...)